FDPS Antikörper

Produktnummer ABIN2856081

Produktdetails anti-FDPS Antikörper

Target: FDPS (Farnesyl Diphosphate Synthase (FDPS))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FDPS Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunofluorescence (IF)

Kreuzreaktivität: Human, Maus, Ratte

Produktmerkmale: Rabbit Polyclonal antibody to FDPS (farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase))
FDPS antibody [N1C3]

Aufreinigung: Purified by antigen-affinity chromatography.

Immunogen: Recombinant protein encompassing a sequence within the center region of human FDPS. The exact sequence is proprietary.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

Kommentare:

Positive Control: Mouse brain , rat liver

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.75 mg/mL

Buffer: 1XPBS pH 7, 20 % Glycerol, 0.025 % ProClin 300

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Details zu FDPS

Target: FDPS (Farnesyl Diphosphate Synthase (FDPS))

Andere Bezeichnung: farnesyl diphosphate synthase (FDPS Produkte)

Synonyme: CG12389 antikoerper, DmFPPS antikoerper, DmFPPSase antikoerper, DmFPS antikoerper, Dmel\\CG12389 antikoerper, FPS antikoerper, fpps antikoerper, fps antikoerper, l(2)k06103 antikoerper, v(2)k03514 antikoerper, NCU01175.1 antikoerper, 16.m00760 antikoerper, DDBDRAFT_0206220 antikoerper, DDBDRAFT_0215017 antikoerper, DDB_0206220 antikoerper, DDB_0215017 antikoerper, FPPS antikoerper, Ac2-125 antikoerper, (2E antikoerper, 6030492I17Rik antikoerper, AI256750 antikoerper, Fdpsl1 antikoerper, mKIAA1293 antikoerper, Farnesyl pyrophosphate synthase antikoerper, farnesyl diphosphate synthase antikoerper, farnesyl diphosphate synthase L homeolog antikoerper, farnesyl pyrophosphate synthase antikoerper, farnesyl pyrophosphate synthetase antikoerper, farnesyl-pyrophosphate synthetase antikoerper, FDP synthase antikoerper, Farnesyl pyrophosphate synthetase antikoerper, farnesyl diphosphate synthetase antikoerper, farnesyl pyrophosphate synthase 1 antikoerper, Fpps antikoerper, fdps antikoerper, fdps.L antikoerper, MGG_08649 antikoerper, TP03_0857 antikoerper, Tb09.160.4300 antikoerper, fpp antikoerper, BBOV_I000120 antikoerper, fps antikoerper, fpps antikoerper, FDPS antikoerper, Fdps antikoerper, fps1 antikoerper

Hintergrund: This gene encodes an enzyme that catalyzes the production of geranyl pyrophosphate and farnesyl pyrophosphate from isopentenyl pyrophosphate and dimethylallyl pyrophosphate. The resulting product, farnesyl pyrophosphate, is a key intermediate in cholesterol and sterol biosynthesis, a substrate for protein farnesylation and geranylgeranylation, and a ligand or agonist for certain hormone receptors and growth receptors. Drugs that inhibit this enzyme prevent the post-translational modifications of small GTPases and have been used to treat diseases related to bone resorption. Multiple pseudogenes have been found on chromosomes 1, 7, 14, 15, 21 and X. Multiple transcript variants encoding different isoforms have been found for this gene.

Cellular Localization: Cytoplasm

Molekulargewicht: 48 kDa

Gen-ID: 2224

UniProt: P14324

Pathways: Regulation of Muscle Cell Differentiation